Harrow HROW
$30.41 −$1.72 (-5.35%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.30 -0.36%
Open$31.95
Prev close$32.13
Day range$30.32 – $32.43
Volume911.8K
Market cap$1.14B
P/E (TTM)–
Dividend yield–
HROW Stock News
Headlines matching Harrow or the HROW ticker, most recent first.
- Leerink Partners Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $45
- Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
- Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Caris Life Sciences, Inc. (CAI) Positive
- BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63
- Analysts' Top NA Picks: Harrow Health (HROW), Scribe Therapeutics Inc. (SCTX)
- Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)
- H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $70
- Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $88
- Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Amentum Holdings, Inc. (AMTM) Positive
- B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60
- Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating, Announces Target Price $59
- H.C. Wainwright Remains a Buy on Harrow Health (HROW)
- B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $60 Negative
- Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $88 Negative
- Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Hims & Hers Health (HIMS) and ArriVent BioPharma, Inc. (AVBP)
No comments yet — be the first to weigh in on HROW.
Sign in to join the discussion.